GGrantIndex
Sort

326,823 grants matching clinical trial

NIAMS: CORT

$1,622,952
Robert W Simms · Boston University Medical Campus · P50 · FY2015 · AR

Innovative Strategies for Improved outcomes in Nephrolithiasis

$1,622,918
Michael R Bailey · University Of Washington · P01 · FY2018 · DK

NIAMS: CORT

$1,622,905
Robert A Lafyatis · Boston University Medical Campus · P50 · FY2014 · AR

NOVEL IMMUNE BASED THERAPIES FOR MULTIPLE MYELOMA

$1,622,897
Dana-Farber Cancer Institute · P01 · FY2000 · CA

MULTICENTER VITAMIN E TRIAL-PERSONS WITH DOWN SYNDROME

$1,622,839
Institute For Basic Res In Dev Disabil · R01 · FY2003 · AG

Development of a Chimeric Syphilis Vaccine Candidate to Combat Local, Disseminated and Congenital Syphilis Infection

$1,622,474
Caroline E Cameron · University Of Victoria · U01 · FY2024 · AI

1/2 Trauma Resuscitation with Group O Whole Blood Or Products (TROOP) Trial

$1,622,403
Jan O Jansen · University Of Alabama At Birmingham · UH3 · FY2023 · HL

CCNY/MSK Cancer Center Partnership, Training and Community Outreach

$1,622,324
Karen Hubbard · City College Of New York · U54 · FY2008 · CA

Mitochondrial Encephalomyopathies and Mental Retardation

$1,622,320
Salvatore Dimauro · Columbia University Health Sciences · P01 · FY2009 · HD

Main Administrative Core

$1,622,133
Anne M Murray · Hennepin Healthcare Research Institute · U19 · FY2020 · AG

Group-Based Mindfulness for Patients with Chronic Low Back Pain in the Primary Care

$1,622,076
Natalia E. Morone · Boston Medical Center · UH3 · FY2021 · AT

Involvement Of Human Viruses Associated With Chronic Neurologic Disease

$1,621,724
Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS

Preclinical evaluation of HIV rectal microbicides

$1,621,723
Ian Michael McGowan · University Of California Los Angeles · U19 · FY2008 · AI

Effectiveness of Implementing an Intensive Blood Pressure Reduction Intervention on Cognitive Decline in Low-income and Minority Hypertensive Patients

$1,621,602
Katherine Teresa Mills · Tulane University Of Louisiana · R33 · FY2023 · AG

Laboratory And Preclinical Studies Of Flaviviruses

$1,621,584
Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

The Memorial Sloan Kettering Cancer Center SPORE in Leukemia

$1,621,553
Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA

The North American Mitochondrial Disease Consortium (NAMDC)

$1,621,474
Michio Hirano · Columbia University Health Sciences · U54 · FY2021 · NS

Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment

$1,621,237
Luis J. Montaner · Wistar Institute · R01 · FY2023 · DA

CircuLite's Circulatory Support System in Children and Infants

$1,621,110
Gail G Farnan · Circulite, Inc. · R44 · FY2011 · HL

COVID-19: NIAID Regulatory Support Center

$1,621,076
Rafi Asimah · Technical Resources International, Inc. · N01 · FY2020 · AI

ETIB Clinical Research Core

$1,620,926
Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2014 · CA

ETIB Clinical Trials

$1,620,926
Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Wake Forest NCORP Research Base

$1,620,862
Glenn J Lesser · Wake Forest University Health Sciences · UG1 · FY2021 · CA

IL-2:IL-15 : implications for cancer therapy

$1,620,799
Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA

Novel Heterologous Adenovirus Prime-Boost HIV-1 Vaccine

$1,620,774
Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2009 · AI